Should biologic agents be stopped before surgery for inflammatory bowel disease?

Impact of Preoperative Immunosuppressive Agents on Postoperative Outcomes in Crohn’s Disease

(2014) Usama Ahmed Ali et al.   DISEASES OF THE COLON & RECTUM

Preoperative infliximab use and postoperative complications in Crohn's disease: A systematic review and meta-analysis

(2014) Zhi-Ping Yang et al.   International Journal of Surgery

Meta-analysis: effect of preoperative infliximab use on early postoperative complications in patients with ulcerative colitis undergoing abdominal surgery

(2012) Z. Yang et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Therapeutic Drug Monitoring of Tumor Necrosis Factor Antagonists in Inflammatory Bowel Disease

(2012) Ingrid Ordás et al.   Clinical Gastroenterology and Hepatology

Preoperative biological therapy and short-term outcomes of abdominal surgery in patients with inflammatory bowel disease

(2012) Matti Waterman et al.   GUT

Anti-tumor necrosis factor and postoperative complications in Crohnʼs disease: systematic review and meta-analysis

(2012) Uri Kopylov et al.   INFLAMMATORY BOWEL DISEASES

Preoperative Infliximab is not Associated with an Increased Risk of Short-Term Postoperative Complications After Restorative Proctocolectomy and Ileal Pouch-Anal Anastomosis

(2011) Melanie L. Gainsbury et al.   JOURNAL OF GASTROINTESTINAL SURGERY

Ulcerative Colitis

(2011) Silvio Danese et al.   NEW ENGLAND JOURNAL OF MEDICINE

Trends in Surgery for Crohnʼs Disease in the Era of Infliximab

(2010) Douglas W. Jones et al.   ANNALS OF SURGERY

Corticosteroids but not infliximab increase short-term postoperative infectious complications in patients with ulcerative colitis

(2009) M. Ferrante et al.   INFLAMMATORY BOWEL DISEASES

World Gastroenterology Organization Practice Guidelines for the Diagnosis and Management of IBD in 2010

(2009) Charles N. Bernstein et al.   INFLAMMATORY BOWEL DISEASES

Infliximab in Ulcerative Colitis is Associated with an Increased Risk of Postoperative Complications After Restorative Proctocolectomy

(2008) I. J. Mor et al.   DISEASES OF THE COLON & RECTUM

Risk factors for opportunistic infections in infliximab-treated patients: the importance of screening in prevention

(2008) C. Garcia-Vidal et al.   EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES

Perioperative Treatment with Infliximab in Patients with Crohn’s Disease and Ulcerative Colitis is Not Associated with an Increased Rate of Postoperative Complications

(2008) Hiroko Kunitake et al.   JOURNAL OF GASTROINTESTINAL SURGERY

Use of Infliximab within 3 Months of Ileocolonic Resection is Associated with Adverse Postoperative Outcomes in Crohn’s Patients

(2008) Kweku A. Appau et al.   JOURNAL OF GASTROINTESTINAL SURGERY